About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
14 Aug 2020
Appendix 2A - Underwriter Options
14 Aug 2020
Results of Meeting
14 Aug 2020
Noxopharm August 2020 EGM Corporate Presentation
11 Aug 2020
Peer-Reviewed Publication Strengthens Case For Veyonda
6 Aug 2020
Noxopharm Extraordinary General Meeting Reminder
29 Jul 2020
Noxopharm June 2020 Quarterly Activities Report & Appendix 4C
24 Jul 2020
Change of Director's Interest Notice - FB
24 Jul 2020
Notice of Contravention of Listing Rule 10.11
23 Jul 2020
Noxopharm Discusses Converting Cold to Hot Cancer Tumours
22 Jul 2020
Receipt of cash payment for collateral shares
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
